Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × WW Domain-Containing Oxidoreductase × 1 year × Clear all

Sponsor

Conditions

Solid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Head and Neck Fibrosis 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 44 Rituximab 31 fludarabine 27 Magnetic Resonance Spectroscopy 13 Doxorubicin 13 Specimen Handling 12 Prednisone 12 Bendamustine Hydrochloride 12 fludarabine phosphate 11 Vincristine 11 Etoposide 11 pirtobrutinib 10 obinutuzumab 9 Lenalidomide 9 Biopsy 8 venetoclax 7 polatuzumab vedotin 7 glofitamab 7 Immunotherapy, Adoptive 7 zanubrutinib 6 pembrolizumab 6 etoposide phosphate 6 tafasitamab 5 ibrutinib 5 acalabrutinib 5 Leukapheresis 5 Dexamethasone 5 Carboplatin 5 tazemetostat 4 loncastuximab tesirine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡